ACE2 and carcinoma: The exact underlying mechanism for the upregulation of ACE-2 in GI adenoma and carcinoma is still unknown and several potential explanatory mechanisms have been suggested, including local inflammation in metaplasia [60], since expression of ACE-2 and TMPRSS2 were found to be enhanced in the rectum of patients with inflammatory bowel disease [67].